{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:17:23Z","timestamp":1790842643299,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.03.040","type":"journal-article","created":{"date-parts":[[2018,3,31]],"date-time":"2018-03-31T00:15:43Z","timestamp":1522455343000},"page":"2694-2704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["African swine fever virus (ASFV) protection mediated by NH\/P68 and NH\/P68 recombinant live-attenuated viruses"],"prefix":"10.1016","volume":"36","author":[{"given":"Carmina","family":"Gallardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena G.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"P\u00e9rez-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Nogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"de Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel L.","family":"Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Revilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.03.040_b0005","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3201\/eid1412.080591","article-title":"African swine fever virus isolate, Georgia, 2007","volume":"14","author":"Rowlands","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.040_b0010","doi-asserted-by":"crossref","unstructured":"Arias M, de la Torre A, Dixon L, Gallardo C, Jori F, Laddomada A, et al. Approaches and perspectives for development of african swine fever virus vaccines. Vaccines (Basel) 2017:5.","DOI":"10.3390\/vaccines5040035"},{"key":"10.1016\/j.vaccine.2018.03.040_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vetmic.2016.10.003","article-title":"Challenges for African swine fever vaccine development \u2013 \u201c\u2026 perhaps the end of the beginning.\u201d","volume":"206","author":"Rock","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0020","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.vaccine.2014.05.051","article-title":"Modern adjuvants do not enhance the efficacy of an inactivated African swine fever virus vaccine preparation","volume":"32","author":"Blome","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.040_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01314703","article-title":"The immunological response of pigs and guinea pigs to antigens of African swine fever virus","volume":"74","author":"Forman","year":"1982","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0065-3527(08)60714-9","article-title":"African swine fever","volume":"35","author":"Mebus","year":"1988","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2018.03.040_b0035","first-page":"475","article-title":"Antibody response to inactivated preparations of African swine fever virus in pigs","volume":"28","author":"Stone","year":"1967","journal-title":"Am J Veter Res"},{"key":"10.1016\/j.vaccine.2018.03.040_b0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/viro.1994.1311","article-title":"African swine fever virus structural protein p72 contains a conformational neutralizing epitope","volume":"201","author":"Borca","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.03.040_b0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/viro.1998.9068","article-title":"The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response","volume":"243","author":"Gomez-Puertas","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.03.040_b0050","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1128\/JVI.70.8.5689-5694.1996","article-title":"Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization","volume":"70","author":"Gomez-Puertas","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0055","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2460\/ajvr.1986.47.06.1249","article-title":"Inhibition of African swine fever infection in the presence of immune sera in vivo and in vitro","volume":"47","author":"Ruiz Gonzalvo","year":"1986","journal-title":"Am J Veter Res"},{"key":"10.1016\/j.vaccine.2018.03.040_b0060","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1006\/viro.1993.1515","article-title":"Virulent African swine fever virus isolates are neutralized by swine immune serum and by monoclonal antibodies recognizing a 72-kDa viral protein","volume":"196","author":"Zsak","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.03.040_b0065","doi-asserted-by":"crossref","first-page":"e40942","DOI":"10.1371\/journal.pone.0040942","article-title":"DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies","volume":"7","author":"Argilaguet","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.03.040_b0070","doi-asserted-by":"crossref","first-page":"13322","DOI":"10.1128\/JVI.01893-14","article-title":"Expression library immunization can confer protection against lethal challenge with African swine fever virus","volume":"88","author":"Lacasta","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.virol.2003.11.011","article-title":"Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection","volume":"319","author":"Neilan","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.03.040_b0080","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01428-17","article-title":"Deletion of the African swine fever virus gene DP148R does not reduce virus replication in culture but reduces virus virulence in pigs and induces high levels of protection against challenge","author":"Reis","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0085","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01058-17","article-title":"BA71DeltaCD2: a new recombinant live attenuated African swine fever virus with cross-protective capabilities","author":"Monteagudo","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0090","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1128\/JVI.00554-15","article-title":"African swine fever virus georgia isolate harboring deletions of MGF360 and MGF505 genes is attenuated in swine and confers protection against challenge with virulent parental virus","volume":"89","author":"O'Donnell","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0095","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1128\/JVI.00969-15","article-title":"African swine fever virus Georgia 2007 with a deletion of virulence-associated gene 9GL (B119L), when administered at low doses, leads to virus attenuation in swine and induces an effective protection against homologous challenge","volume":"89","author":"O'Donnell","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2016.05.014","article-title":"African swine fever virus Georgia isolate harboring deletions of 9GL and MGF360\/505 genes is highly attenuated in swine but does not confer protection against parental virus challenge","volume":"221","author":"O'Donnell","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.03.040_b0105","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1016\/j.vaccine.2016.08.011","article-title":"Deletion of African swine fever virus interferon inhibitors from the genome of a virulent isolate reduces virulence in domestic pigs and induces a protective response","volume":"34","author":"Reis","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.040_b0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2013.04.028","article-title":"Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88\/3 decreases its ability to protect against challenge with virulent virus","volume":"443","author":"Abrams","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.03.040_b0115","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1099\/vir.0.80058-0","article-title":"Characterization of pathogenic and non-pathogenic African swine fever virus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal","volume":"85","author":"Boinas","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0120","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/j.vaccine.2011.04.052","article-title":"Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation","volume":"29","author":"King","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.040_b0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1099\/0022-1317-82-3-513","article-title":"The non-haemadsorbing African swine fever virus isolate ASFV\/NH\/P68 provides a model for defining the protective anti-virus immune response","volume":"82","author":"Leitao","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0130","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1099\/vir.0.81038-0","article-title":"In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus","volume":"86","author":"Oura","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.11.021","article-title":"Different routes and doses influence protection in pigs immunised with the naturally attenuated African swine fever virus isolate OURT88\/3","volume":"138","author":"Sanchez-Cordon","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2018.03.040_b0140","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.4049\/jimmunol.180.4.2429","article-title":"A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300","volume":"180","author":"Granja","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/JVI.01663-08","article-title":"African swine fever virus blocks the host cell antiviral inflammatory response through a direct inhibition of PKC-theta-mediated p300 transactivation","volume":"83","author":"Granja","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0150","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1128\/JVI.74.20.9412-9420.2000","article-title":"African swine fever virus protein A238L interacts with the cellular phosphatase calcineurin via a binding domain similar to that of NFAT","volume":"74","author":"Miskin","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0155","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/JVI.75.6.2535-2543.2001","article-title":"African swine fever virus IAP homologue inhibits caspase activation and promotes cell survival in mammalian cells","volume":"75","author":"Nogal","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0160","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1128\/JVI.76.8.3936-3942.2002","article-title":"African swine fever virus IAP-like protein induces the activation of nuclear factor kappa B","volume":"76","author":"Rodriguez","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00705-010-0846-2","article-title":"The African swine fever virus lectin EP153R modulates the surface membrane expression of MHC class I antigens","volume":"156","author":"Hurtado","year":"2011","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0170","doi-asserted-by":"crossref","unstructured":"Hurtado C, Granja AG, Bustos MJ, Nogal ML, Gonzalez de Buitrago G, de Yebenes VG, et al. The C-type lectin homologue gene (EP153R) of African swine fever virus inhibits apoptosis both in virus infection and in heterologous expression. Virology 2004;326:160\u201370.","DOI":"10.1016\/j.virol.2004.05.019"},{"key":"10.1016\/j.vaccine.2018.03.040_b0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virusres.2012.10.013","article-title":"Identification and utility of innate immune system evasion mechanisms of ASFV","volume":"173","author":"Correia","year":"2013","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.03.040_b0180","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF01249690","article-title":"Antigenic relationships among strains of African swine fecre virus","volume":"45","author":"Vigario","year":"1974","journal-title":"Arch Gesamte Virusforsch"},{"key":"10.1016\/j.vaccine.2018.03.040_b0185","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1128\/JCM.00857-15","article-title":"Assessment of African swine fever diagnostic techniques as a response to the epidemic outbreaks in eastern european union countries: how to improve surveillance and control programs","volume":"53","author":"Gallardo","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0190","doi-asserted-by":"crossref","unstructured":"Carrascosa AL, Bustos MJ, de Leon P. Methods for growing and titrating African swine fever virus: field and laboratory samples. Curr Protoc Cell Biol. 2011; Chapter 26:Unit 26 14.","DOI":"10.1002\/0471143030.cb2614s53"},{"key":"10.1016\/j.vaccine.2018.03.040_b0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4049\/jimmunol.176.1.451","article-title":"The viral protein A238L inhibits TNF-alpha expression through a CBP\/p300 transcriptional coactivators pathway","volume":"176","author":"Granja","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0200","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/viro.1999.0080","article-title":"African swine fever virus EP153R open reading frame encodes a glycoprotein involved in the hemadsorption of infected cells","volume":"266","author":"Galindo","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.03.040_b0205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/JVI.54.2.337-344.1985","article-title":"Purification and properties of African swine fever virus","volume":"54","author":"Carrascosa","year":"1985","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0210","doi-asserted-by":"crossref","first-page":"53736","DOI":"10.1074\/jbc.M406620200","article-title":"The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway","volume":"279","author":"Granja","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.03.040_b0215","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.1128\/JVI.00862-06","article-title":"Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65\/RelA acetylation and p300 transactivation","volume":"80","author":"Granja","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.040_b0220","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1074\/jbc.273.9.5405","article-title":"Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein","volume":"273","author":"Revilla","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.03.040_b0225","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/tbed.12431","article-title":"Experimental transmission of African swine fever (ASF) low virulent isolate NH\/P68 by surviving pigs","volume":"62","author":"Gallardo","year":"2015","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2018.03.040_b0230","first-page":"199","article-title":"Quelques aspects morphologiques des suites de la vaccination contre la peste porcine Africaine (virose L) au Portugal","volume":"63","author":"Petisca","year":"1965","journal-title":"Bulletin de l'Office International des Epizooties"},{"key":"10.1016\/j.vaccine.2018.03.040_b0235","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1111\/tbed.12303","article-title":"Immunization of African indigenous pigs with attenuated genotype I african swine fever virus OURT88\/3 induces protection against challenge with virulent strains of genotype I","volume":"63","author":"Mulumba-Mfumu","year":"2016","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2018.03.040_b0240","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1038\/s41598-017-09948-x","article-title":"Phenotyping and susceptibility of established porcine cells lines to African Swine Fever Virus infection and viral production","volume":"7","author":"Sanchez","year":"2017","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18303852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18303852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:40:04Z","timestamp":1751528404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18303852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":48,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X18303852"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"African swine fever virus (ASFV) protection mediated by NH\/P68 and NH\/P68 recombinant live-attenuated viruses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}